
EORTC-1333-GUCG/PEACE III trial endpoint reached
12 Jul 2024

EORTC-1333-GUCG/PEACE III Trial Statement
28 Jun 2024

Completion of Patient Recruitment for International TIGER Study
19 Dec 2022

EORTC Completes Patient Recruitment to Study of Treatment for Rare Cancer High-Grade Uterine Sarcoma
18 Oct 2021

Combined hormone/radiotherapy treatment improves event-free and disease-free survival in patients with localised intermediate risk prostate cancer; long-term results from EORTC Trial 22991
30 Jul 2021

Revisiting classification in testicular cancer: what has changed?
17 May 2021

Genito-urinary cancer research looks to the future
2 Dec 2020

Prostate cancer patient webinar underlines the importance of measuring the Quality of Life of caregivers
12 Nov 2020